Unexpected Complication During Stent Placement for Esophageal Cancer
Journal of Otorhinolaryngology and Facial Plastic Surgery,
Vol. 9 No. 1 (2023),
2 Shahrivar 2023
,
Page 1-4
https://doi.org/10.22037/orlfps.v9i1.41645
Abstract
Background: Due to the delay in esophageal cancer until the late stages, its mortality rate is relatively high. One of the most common presentations of advanced esophageal cancer is dysphagia. Esophageal stenting is a palliative treatment modality to resolve dysphagia and restore oral intake. Despite this advantage, stenting has various complications.
Aim: We reported a case of active bleeding after esophageal stenting.
Case presentation: A case of a complication caused by an esophageal stent placement for carcinoma is presented. The placement of the stent was difficult under fluoroscopic control, which led to some pushing, resulting in a wound in the pharynx with active bleeding without perforation. The bleeding was successfully controlled by the surgeon. Therefore, the patient was postponed a few days later and we preferred this time to put a stent through the scope without complications.
Conclusion: Active bleeding is one of the esophageal stenting complications. In this article, we reported a middle-aged woman with advanced esophageal cancer who underwent esophageal stenting. Afterward, she developed active bleeding, which was successfully managed.
- Esophageal carcinoma; Esophageal stenting; Active bleeding;
How to Cite
References
(1) Bray F, Ferlay J, Soerjomataram I, Siegel RL, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortal- ity worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
(2) P. Hindy, J. Hong, Y. Lam-Tsai, and F. Gress, “A comprehensive review of esophageal stents,” Gastroenterol Hepatol (N Y), vol. 8,no. 8, pp. 526–534, 2012.
(3) Cwikiel W, Tranberg KG, Cwikiel M, Lillo-Gil R (1998) Malignant dysphagia: Palliation with esophageal stents—long- term results in 100 patients. Radiology 207:513–518.
(4) Adam A, Ellul J, Watkinson AF et al (1997) Palliation of inop- erable esophageal carcinoma: a prospective randomized trial of laser therapy and stent placement. Radiology 202:344–348.
(5) Hill JL, Norberg HP, Smith MD, Young JA, Reyes HM. Clinical technique and success of the esophageal stent to prevent corrosive strictures. J Pe- diatr Surg 1976; 11: 443-50.
(6) Varadarajulu S, Banerjee S, Barth B, Desilets D, Kaul V, Kethu S, Pedrosa M, Pfau P, Tokar J, Wang A, et al. Enteral stents. Gastrointest Endosc 2011; 74: 455-64.
(7) Domschke W, Foerster EC, Matek W, Rödl W. Self-expanding mesh stent for esophageal cancer stenosis. Endoscopy 1990; 22: 134-6.
(8) Anderson MJ, Sippey M. Endoscopic stent placement: indications and success rates. Ann Laparosc Endosc Surg 2019;4:55.
(9) Bethge N. Sommer A. Vakil N. Palliation of malignant esophageal obstruction due to intrinsic and extrinsic lesions with expandable metal stents. Am J Gastroenterol 1998;93:1829.
(10) Na HK, Song HY, Kim JH, Park JH, Kang MK, Lee J, Oh SJ. How to design the optimal self-expandable oesophageal metallic stents: 22 years of ex- perience in 645 patients with malignant strictures. Eur Radiol 2013; 23: 786-96.
(11) Sharma P, Kozarek R; Practice Parameters Committee of American Col- lege of Gastroenterology. Role of esophageal stents in benign and malig- nant diseases. Am J Gastroenterol 2010; 105: 258-73.
(12) Nagahama T, Maruyama M, Kato K, Shinoura H, Hasegawa K, TakashimaI, Ebuchi M. Complication after self expandable metallic stent for esophageal cancer. Gan To KagakuRyoho 2003; 30: 1750-3.
(13) Spaander MC, Baron TH, Siersema PD, Fuccio L, Schumacher B, Escor- sell À, Garcia-Pagán JC, Dumonceau JM, Conio M, de Ceglie A, et al. Eso- phageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy 2016; 48: 939-48.
- Abstract Viewed: 271 times
- PDF Downloaded: 314 times